Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1989 | 03-1989 | 12-1988 | 09-1988 | 06-1988 | |
| Sales | 5,446 | 5,319 | 5,050 | 4,315 | 4,261 |
| Cost of Goods | 3,377 | 3,393 | 2,970 | 2,913 | 2,876 |
| Gross Profit | 2,069 | 1,926 | 2,080 | 1,402 | 1,385 |
| Operating Expenses | 1,503 | 1,398 | 2,119 | 1,769 | 1,780 |
| Operating Income | 943 | 921 | 931 | 546 | 481 |
| Interest Expense | 114 | 61 | 4 | 13 | 4 |
| Other Income | 26 | 0 | 1 | 0 | 4 |
| Pre-tax Income | 855 | 860 | 927 | 533 | 481 |
| Income Tax | 372 | 374 | 424 | 238 | 201 |
| Net Income Continuous | 483 | 486 | 503 | 295 | 280 |
| Net Income | $483 | $486 | $503 | $295 | $280 |
| EPS Basic Total Ops | N/A | 4.58 | 4.76 | 2.77 | 2.64 |
| EPS Basic Continuous Ops | N/A | 4.58 | 4.76 | 2.77 | 2.64 |
| EPS Diluted Total Ops | N/A | 4.58 | 4.76 | 2.77 | 2.64 |
| EPS Diluted Continuous Ops | N/A | 4.58 | 4.76 | 2.77 | 2.64 |
| EBITDA(a) | $943 | $921 | $931 | $546 | $481 |